Abstract
Management of #patients suffering from Drug Resistant #Epilepsy has
changed dramatically over last few decades. Neurologists and
Neurosurgeons of current generation have an advantage over #past generations to have dramatically improved #biotechnology to help them
managing these patients. Recently, biotechnology has provided us with
mobile health & wearable devices to early & promptly detect the #seizures in ambulatory patients during their routine activities. This is
an edge; which neuroscientists were deprived of in the past. Epilepsy is a brain disorder characterized by recurrent unprovoked
seizures which occurs due to #abnormal excessive electrical activity in
the brain. This in turn is often reported by the patient and the
accompanying persons. Commonly, it is also called as fits or seizures.
Seizures can occur with or without impairment of consciousness and it
depend on which part of the brain is affected in epilepsy. Approximately
50 million people in the world suffer from epilepsy, of whom 80% live
in resource restricted countries.
For more articles on BJSTR Journals please click here: https://biomedres.us/
For more Biomedical Intervention Articles on BJSTR
Biotechnology and #EpilepsyPatient by Jitender Chaturvedi in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.